期刊文献+

左炔诺孕酮宫内缓释系统治疗子宫腺肌病计划外取出和脱落情况及其相关因素分析 被引量:17

Analysis of unplanned taking-out and expulsion of LNG-IUS and related factors during the treatment of symptomatic adenomyosis
原文传递
导出
摘要 目的探讨左炔诺孕酮宫内缓释系统(LNG-IUS)治疗症状性子宫腺肌病[重度痛经和(或)经量过多]过程中计划外取出和脱落的情况。方法北京协和医院妇产科2006年12月至2014年12月对超声诊断为子宫腺肌病的重度痛经和(或)经量过多患者给予LNG-IUS治疗,在放置前后评估患者的痛经症状、疼痛评分、出血评分、生化指标、体格参数、月经模式以及不良反应,分析LNG-IUS计划外取出和脱落情况及其相关因素。结果符合入选标准的病例总计1100例。LNG-IUS放置60个月的累积取出率和脱落率分别为9%和16%,66%的取出和69%的脱落发生在放置12个月以内。LNG-IUS计划外取出的常见原因是月经模式改变或不良反应(75.0%)以及感觉治疗效果不佳(55.8%)。回归分析发现,腹腔镜术中放置LNG-IUS能够降低计划外取出(OR=0.63,95%CI 0.40~0.99,P=0.040),而放置前应用促性腺激素释放激素激动剂(Gn RH-a)和经量过多的症状是放置后脱落的相关因素(OR分别为0.50和1.71,95%CI分别为0.34~0.74和1.20~2.43,P值分别为〈0.001和0.003)。取出和脱落LNG-IUS与治疗结局、月经模式变化以及实际的不良反应均无显著相关。结论大部分LNG-IUS的取出和脱落情况发生在放置后12个月内。妇科腹腔镜术中放置LNG-IUS能够减少患者的计划外取出。经量过多的子宫腺肌病患者放置LNG-IUS后脱落率显著增加,放置前应用Gn RH-a可以降低脱落率。取出和脱落与治疗结局、月经模式变化以及不良反应等均无关。 Objective To investigate the prevalence of unplanned taking-out and spontaneously expulsion of levonorgestrel-releasing intrauterine system(LNG-IUS) and related factors during the treatment of symptomatic adenomyosis(severe dysmenorrhea and/or menorrhea) in a prospective cohort study.Methods From December,2006 to December,2014,patients with symptomatic adenomyosis diagnosed by transvaginal ultrasound in Peking Union Medical College Hospital were given the treatment of LNG-IUS.Before and after placement of LNG-IUS,all the parameters were recorded,including symptoms and scores of dysmenorrhea,menstruation scores,biochemical indicators,physical parameters,menstruation patterns and adverse effects.The prevalence of unplanned taking-out and expulsion of LNG-IUS and dependent factors were analyzed.Results There were 1100 cases that met inclusion criteria.In 60 months after placement of LNG-IUS,the accumulative ratios of taking-out and expulsion were 9% and 16% respectively,66% taking-out and 69% expulsion happened in 12 months.Most common reasons reported by taking-out patient were changes of menstruation patterns or adverse effects(75.0%),and feeling unsatisfied about the treatment effects(55.8%).Placement during gynecological laparoscopies could reduce taking-out of LNG-IUS(OR 0.63,95% CI 0.40~0.99,P=0.040).Gn RH-a treatment before placement and symptom of menorrhea were independent factors predicting expulsion of LNG-IUS(OR were 0.50 and 1.71,95%CI were 0.34~0.74 and 1.20~2.43,P values were 0.001 and 0.003).Prevalence of taking-out and expulsion had no relation with treatment effects,changes of menstruation patterns or actual adverse effects.Conclusion Most taking-out and expulsion of LNG-IUS happens in 12 months after placement.Placement during gynecological laparoscopies reduces takingout of LNG-IUS.Patients of menorrhea have higher probability of expulsion,while Gn RH-a treatment before placement can decrease rate of expulsion.Taking-out or expulsion is not related to treatment effects,changes of menstruation patterns or adverse effects.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2016年第11期1088-1092,共5页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 子宫腺肌病 左炔诺孕酮宫内缓释系统 月经模式 腹腔镜手术 adenomyosis levonorgestrel-releasing intrauterine system menstruation patterns laparoscopy
  • 相关文献

参考文献4

二级参考文献46

  • 1冷金花,郎景和.子宫腺肌病的手术治疗[J].实用妇产科杂志,2006,22(1):10-12. 被引量:109
  • 2王宏,冷金花,郎景和,刘珠凤,孙大为,朱兰,樊庆泊.子宫肌腺症的临床病理特点及手术指征的探讨[J].现代妇产科进展,2006,15(7):493-496. 被引量:28
  • 3邓姗,郎景和,冷金花,刘珠凤,孙大为,朱兰.左炔诺孕酮宫内缓释系统用于防治子宫内膜异位症和子宫腺肌病的临床观察[J].中华妇产科杂志,2006,41(10):664-668. 被引量:71
  • 4Flaherty SA, Pain measurement tools for clinical practice and research[J]. AANA J, 1996,64(2) :133-140.
  • 5Yaman C, Jesacher K, Polz W. Accuracy of three-dimensional transvaginal ultrasound in uterus volume measurements: comparison with two-dimensional ultrasound[J]. Ultrasound Med Biol, 2003,29(12) :1681-1684.
  • 6Fraser IS, Critchley HOD, Munro MG, et al. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of uterine bleeding [J]. FertilSteril, 2007,87(3) :466-476.
  • 7Cho SH, Nam A, Kim HY, et al. Clinical effects of the levonorgestrel releasing intrauterine device in patients with adenomyosis[J]. Am J Obstet Gynecol, 2008, 198 (4): 373e1-e7.
  • 8Sheng J, Zhang WY, Zhang JP, et al. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis[J]. Contraception, 2009,79(3):189-193.
  • 9Rizkalla HF, Higgins M, Kelehan P, et al. Pathological findings associated with the presence of a Mirena intrauterine system at hysterectomy[J]. Int J Gynecol Pathol, 2008,27 (1) :74-78.
  • 10Ko HS, Singh K. The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia [J]. J Thromb Haemost, 2007,5(1) :133-138.

共引文献1220

同被引文献115

引证文献17

二级引证文献147

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部